374Water Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 14, 2024, details a material definitive agreement entered into by 374Water Inc. (SCWO), a Delaware corporation. The report covers a registered direct offering that closed on November 18, 2024.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $12.2 million before deducting placement agent fees and offering expenses.
- Securities Issued: 9,783,496 shares of Common Stock and warrants to purchase up to 14,675,244 shares.
- Offering Price: $1.25 per unit (one share plus 1.5 warrants).
- Warrant Terms: Exercise price of $1.125 per share; immediately exercisable; five-year expiration.
- Placement Agent Fees: 5.0% of gross proceeds for investors introduced by the agent; 2.5% for investors introduced by the Company.
- Expense Reimbursement: Up to $75,000 for placement agent expenses.
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement and a Placement Agency Agreement with D. Boral Capital LLC. Key covenants include:
- Lock-Up Period: Officers and directors are restricted from selling or transferring securities for three months following the closing date.
- Issuance Restrictions: The Company agreed not to issue or announce the issuance of Common Stock or equivalents for 90 days, and not to enter into variable rate transactions for 180 days from the agreement date.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, revenue outlook, or specific management commentary regarding future operational performance. The document notes that the agreements contain customary representations, warranties, and indemnification obligations. Investors are directed to the Company's annual and quarterly reports for factual information regarding the current state of affairs.
Key Facts for Investor Verification
- Verify the net proceeds after deducting the 5% or 2.5% placement fees and the $75,000 expense cap.
- Confirm the dilution impact of the 9.78 million new shares and the potential 14.68 million shares from warrant exercises.
- Review the Company's cash position and liquidity status in the most recent 10-Q or 10-K to assess the immediate benefit of the $12.2 million gross proceeds.
- Check for any subsequent filings regarding the use of proceeds or changes in the Company's capital structure within the 90-day issuance restriction period.